Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

Infection and Immunity
T R Kozel

Abstract

The binding of cryptococcal polysaccharide to a non-encapsulated strain of Cryptococcus neoformans was studied. Binding of purified polysaccharide to the yeast was determined by inhibition of phagocytosis and by indirect immunofluorescence techniques. The ability of cryptococcal polysaccharide to prevent phagocytosis of the non-encapsulated strain appears to be directly related to adherence of polysaccharide to the yeast via specific receptors on the cell surface. Addition of varying doses of cryptococcal polysaccharide to non-encapsulated yeast cells inhibited phagocytosis only at polysaccharide concentrations at which the polysaccharide could be demonstrated on the yeast surface by immunofluorescence. Macrophages treated with cryptococcal polysaccharide had no detectable amounts of cryptococcal polysaccharide adherent to their surface, and they had a normal ability to phagocytize the yeast. Kinetic studies showed that inhibition of phagocytosis is directly related to the presence of cryptococcal polysaccharide at the yeast surface rather than to some indirect effect by the polysaccharide on serum components necessary for phagocytosis. Purified polysaccharide from C. neoformans serotypes A, B, C, and D bound to the yeast, but ...Continue Reading

References

Jan 1, 1975·Infection and Immunity·G S Bulmer, J R Tacker
Oct 15, 1974·Mycopathologia et mycologia applicata·T R Kozel, J Cazin
Apr 1, 1972·The Journal of Infectious Diseases·R D DiamondJ E Bennett
Aug 1, 1972·Infection and Immunity·J R TackerG S Bulmer
Jan 1, 1968·Journal of Bacteriology·G S Bulmer, M D Sans
Apr 1, 1968·The Journal of Infectious Diseases·M B Goren, J Warren
Nov 1, 1967·Journal of Bacteriology·G S BulmerC M Gunn
Aug 27, 1960·Annals of the New York Academy of Sciences·H F HASENCLEVER, W O MITCHELL
Aug 1, 1959·Proceedings of the Society for Experimental Biology and Medicine·M L LITTMAN, E TSUBURA

❮ Previous
Next ❯

Citations

Nov 1, 1987·Clinical and Experimental Dermatology·F Jiménez-AcostaM J Sanjurjo
Sep 1, 1993·Arquivos de neuro-psiquiatria·C S LacazJ A Livramento
Feb 24, 2001·Medical Mycology·A Vecchiarelli
Nov 19, 2003·Molecular Microbiology·Amy J Reese, Tamara L Doering
Nov 10, 2005·The Journal of Biological Chemistry·Diane C McFaddenArturo Casadevall
Oct 12, 2011·Immunological Investigations·Michael S Price, John R Perfect
Jun 20, 1983·Mycopathologia·C M RieraR Nobile
Jan 1, 1994·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·B DupontT Sirisanthana
Jul 17, 2003·Cellular Microbiology·Donatella PietrellaAnna Vecchiarelli
May 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T F Patterson, V T Andriole
Feb 28, 2002·American Journal of Respiratory Cell and Molecular Biology·Ling Ling Ma, Christopher H Mody
Aug 21, 2010·Future Microbiology·Michal A OlszewskiGary B Huffnagle
Jan 1, 1979·Scandinavian Journal of Infectious Diseases·W D WelchL S Young
Jan 1, 1993·Virchows Archiv. B, Cell Pathology Including Molecular Pathology·N Sakaguchi
Jul 17, 2001·Molecular Microbiology·L M Pierini, T L Doering
Dec 1, 1981·Sabouraudia·J R GraybillD J Drutz
Dec 10, 2015·Journal of Fungi·Yoon-Dong Park, Peter R Williamson
Feb 1, 1986·Mycopathologia·R A Fromtling, H J Shadomy
Apr 13, 2018·Glycobiology·Zhuo A WangTamara L Doering
May 1, 1992·International Journal of STD & AIDS·R J Coker
Mar 18, 2021·European Journal of Immunology·Keigo UenoYoshitsugu Miyazaki
Aug 1, 1995·Trends in Microbiology·T R Kozel
Dec 15, 2000·Trends in Microbiology·T L Doering
Jun 1, 1982·Journal of Bacteriology·E S JacobsonC C Nicholas
Oct 1, 1979·Infection and Immunity·D P MongaA N Malaviya
Aug 13, 2003·Eukaryotic Cell·Indrani BoseTamara L Doering
Dec 1, 1994·Infection and Immunity·H S EmeryE S Jacobson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.